Legal Name: DEERFIELD MANAGEMENT COMPANY, L.P. SERIES C
Period of report:
Jun 30, 2019
Effectiveness Date:
Aug 14, 2019
Security |
Shares Held / Principal Amount |
Market Value |
Option |
HORIZON THERAPEUTICS PLC (G46188101)
|
6,462,634 |
$155,491k |
|
HORIZON PHARMA INVESTMENT LTD (44052TAB7)
|
136,032,000 |
$150,514k |
|
MYLAN N V (n59465109)
|
7,464,327 |
$142,121k |
|
ORCHARD THERAPEUTICS PLC (68570P101)
|
8,923,600 |
$124,841k |
|
NEVRO CORP (64157FAA1)
|
115,776,000 |
$120,607k |
|
Homology Medicines (438083107)
|
5,760,368 |
$112,730k |
|
AERIE PHARMACEUTICALS INC (00771V108)
|
3,032,987 |
$89,625k |
|
Intersect ENT Inc. (46071F103)
|
3,109,004 |
$70,761k |
|
IMMUNOMEDICS INC (452907108)
|
4,985,383 |
$69,147k |
|
Acceleron Pharma Inc (00434H108)
|
1,305,174 |
$53,617k |
|
INSULET CORP 1.375 11/15/24 (45784PAH4)
|
36,650,000 |
$52,097k |
|
BROOKDALE SENIOR LIVING INC (112463104)
|
7,207,239 |
$51,964k |
|
RA PHARMACEUTICALS (74933V108)
|
1,713,000 |
$51,510k |
|
ICPT 3 1/4 7/1/23 (45845PAA6)
|
57,791,000 |
$51,380k |
|
MYOKARDIA INC (62857M105)
|
997,000 |
$49,990k |
|
Sarepta Therapeutics Inc (803607100)
|
309,025 |
$46,956k |
|
DIPLOMAT PHARMACY INC (25456K101)
|
7,036,670 |
$42,853k |
|
Argenx SE Sponsored ADR (04016X101)
|
281,000 |
$39,784k |
|
VERICEL CORP (92346J108)
|
2,069,601 |
$39,095k |
|
MALLINCKRODT PLC (G5785G107)
|
4,178,219 |
$38,356k |
|
COHERUS BIOSCIENCES INC (19249H103)
|
1,678,022 |
$37,084k |
|
BLUEPRINT MEDICINES CORP (09627Y109)
|
391,254 |
$36,907k |
|
Fate Therapeutics Inc (31189P102)
|
1,702,897 |
$34,569k |
|
ALECTOR INC (014442107)
|
1,746,923 |
$33,192k |
|
SELECT MED HLDGS CORP (81619Q105)
|
2,043,527 |
$32,431k |
|
DEXCOM INC (252131AF4)
|
20,000,000 |
$31,926k |
|
KEMPHARM INC (488445AB3)
|
65,423,000 |
$31,632k |
|
Anaptysbio Inc (032724106)
|
540,529 |
$30,497k |
|
Editas Medicine Inc (28106W103)
|
1,158,841 |
$28,670k |
|
SIENTRA INC (82621J105)
|
4,652,306 |
$28,658k |
|
NATERA INC (632307104)
|
1,002,834 |
$27,658k |
|
PTC THERAPEUTICS INC (69366JAB7)
|
24,877,000 |
$27,557k |
|
MIRATI THERAPEUTICS INC (60468T105)
|
264,600 |
$27,254k |
|
XERIS PHARMACEUTICALS INC (98422L107)
|
2,379,901 |
$27,226k |
|
KALVISTA PHARMACEUTICALS (483497103)
|
1,217,668 |
$26,971k |
|
EHEALTH INC COM (28238P109)
|
310,900 |
$26,768k |
|
DBV TECHNOLOGIES SA-SPON ADR (23306J101)
|
3,201,222 |
$26,314k |
|
DFB HEALTHCARE ACQUISTION CORP UNIT EXP 013023 (23291E208)
|
2,500,000 |
$25,925k |
|
EXACT SCIENCES CORP (30063PAA3)
|
15,000,000 |
$25,846k |
|
STAAR SURGICAL CO COM NEW PAR $0.01 (852312305)
|
876,512 |
$25,752k |
|
NEVRO CORP COM (64157F103)
|
386,000 |
$25,024k |
|
SILK ROAD MEDICAL INC COM (82710M100)
|
499,030 |
$24,183k |
|
BIOCRYST PHARMACEUTICALS (09058v103)
|
6,292,980 |
$23,850k |
|
Invitae Corp (46185L103)
|
995,312 |
$23,390k |
|
MOLINA HEALTHCARE INC (60855R100)
|
150,000 |
$21,471k |
|
PTC THERAPEUTICS INC (69366J200)
|
471,000 |
$21,195k |
|
ARVINAS INC (04335A105)
|
921,234 |
$20,258k |
|
WRIGHT MED GROUP N V (98236JAB4)
|
13,625,000 |
$20,185k |
|
ADDUS HOMECARE CORP (006739106)
|
252,915 |
$18,956k |
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
493,901 |
$18,699k |
|
Reata Pharmaceuticals Inc. (75615P103)
|
197,000 |
$18,587k |
|
SHOCKWAVE MED INC COM (82489T104)
|
312,146 |
$17,820k |
|
HUMANA INC (444859102)
|
67,000 |
$17,775k |
|
KINISKA PHARMACEUTIC (G5269C101)
|
1,310,259 |
$17,741k |
|
AXOGEN INC COM (05463X106)
|
891,306 |
$17,648k |
|
WAVE LIFE SCIENCES LTD (Y95308105)
|
669,260 |
$17,461k |
|
ROCKET PHARMACEUTICALS INC (77313F106)
|
1,137,142 |
$17,057k |
|
CLOVIS ONCOLOGY INC (189464AB6)
|
18,000,000 |
$15,902k |
|
CENTENE CORP DEL (15135B101)
|
303,000 |
$15,889k |
|
ANTHEM INC (036752103)
|
53,000 |
$14,957k |
|
MorphoSys AG (617760202)
|
600,000 |
$14,484k |
|
Rhythm Pharmaceuticals, Inc. (76243J105)
|
623,933 |
$13,727k |
|
DECIPHERA PHARMACEUTICALS IN (24344T101)
|
607,633 |
$13,702k |
|
GALAPAGOS NV (36315X101)
|
101,010 |
$13,023k |
|
GLOBAL BLOOD THERAPEUTICS IN (37890U108)
|
235,000 |
$12,361k |
|
ATHENEX INC (04685N103)
|
621,859 |
$12,313k |
|
Syros Pharmaceuticals Inc (87184Q107)
|
1,268,946 |
$11,750k |
|
TURNING POINT THERAPEUTICS I (90041T108)
|
287,545 |
$11,703k |
|
PHASEBIO PHARMACEUTICALS INC (717224109)
|
851,005 |
$11,165k |
|
SYNLOGIC INC (87166L100)
|
1,107,643 |
$10,080k |
|
TANDEM DIABETES CARE (875372203)
|
152,500 |
$9,839k |
|
ARDELYX INC (039697107)
|
3,461,298 |
$9,311k |
|
INSPIRE MED SYS INC COM (457730109)
|
151,106 |
$9,165k |
|
CHEWY INC CL A (16679L109)
|
261,337 |
$9,147k |
|
ACLARIS THERAPEUTICS INC (00461U105)
|
3,983,025 |
$8,723k |
|
X4 PHARMACEUTICALS INC (98420X103)
|
565,000 |
$8,475k |
|
AVADEL PHARMACEUTICALS PLC (05337M104)
|
2,722,241 |
$7,867k |
|
BRIDGEBIO PHARMA INC (10806X102)
|
290,000 |
$7,821k |
|
SORRENTO THERAPEUTICS INC (83587F202)
|
2,091,461 |
$5,584k |
|
B. Riley Wealth Management, Inc. (016259103)
|
6,052,935 |
$5,387k |
|
TELIGENT INC/NJ (87960WAA2)
|
9,567,000 |
$5,063k |
|
IDEAYA BIOSCIENCES INC (45166A102)
|
425,000 |
$4,233k |
|
BIODELIVERY SCI INTL (09060J106)
|
816,096 |
$3,795k |
|
HARPOON THERAPEUTICS INC (41358P106)
|
285,000 |
$3,705k |
|
MEDICINES CO (584688105)
|
100,000 |
$3,647k |
Put |
ITAMAR MED LTD (465437101)
|
314,136 |
$3,455k |
|
AEGLEA BIOTHERAPEUTICS INC (00773J103)
|
500,046 |
$3,425k |
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
70,000 |
$3,381k |
|
PFENEX INC (717071104)
|
394,255 |
$2,657k |
|
CONSTELLATION PHARMCETICLS I (210373106)
|
183,600 |
$2,255k |
|
NEURONETICS (64131A105)
|
159,000 |
$1,989k |
|
Alpine Immune Sciences Inc (02083G100)
|
415,908 |
$1,751k |
|
EYENOVIA INC (30234E104)
|
300,000 |
$1,290k |
|
ORTHOPEDIATRICS CORP (68752L100)
|
32,000 |
$1,248k |
|
MENLO THERAPEUTICS (586858102)
|
198,451 |
$1,189k |
|
PROTEON THERAPEUTICS INC (74371L109)
|
1,224,899 |
$510k |
|
NEOS THERAPEUTICS INC (64052L106)
|
320,993 |
$414k |
|
Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.
All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.
Recently Searched Firms